Polycyclic aromatic hydrocarbons (PAH) are activated by cytochrome P-450 via two main pathways monooxygenation and one-electron oxidation, with formation of the reactive intermediate diol epoxides and radical cations, respectively. When benzo[a]pyrene (BP) is bound to DNA by cytochrome P-450 in vitro or in vivo, the major adducts, formed by one- electron oxidation, contain BP bound at C-6 to N-7 of Gua (BP-6-N7Gua), C-8 of Gua (BP-6-C8Gua) and N-7 of Ade (BP-6-N7Ade), all lost from DNA by depurination. About 90% of all BP-DNA adducts formed are lost from the DNA by depurination. Rodents treated with BP excrete these adducts. These findings enable us to focus on PAH-DNA adducts formed in vivo and begin to study their biological significance. We propose to measure BP- 6-N7Gua and BP- 6-N7Ade as markers for exposure to BP by using monoclonal antibodies (Mabs). BALB/c mice will be immunized with BP-6- N7Gua (or BP-6-N7Ade) linked through succinimidyl-4-(N- maleimidoethyl)cyclohexane-1-carboxylate (SMCC) to keyhole limpet hemocyanin (KLH). Hybridomas will be developed and assayed for Mabs specific for the adducts. Selected Mabs will be used in ELISA to determine the presence of BP-6-N7Gua and/or BP-6-N7Ade in urine from rats and mice treated with BP and in human urine samples from cigarette smokers and non-smokers.
In Aims #1 and 2, we expect to develop an immunoassay for human exposure to the carcinogen BP in cigarette smoke and air pollution.
In Aim #4, we propose to examine the labile DNA adducts formed by BP and 7, 12-dimethylbenz[a]anthracene (DMBA) by analyzing alkali-labile lesions in a 229 base-pair fragment of pBR322 DNA treated with BP or DMBA in chemical and enzymatic reactions. With these experiments, we will identify the sequence specificity of apurinic sites arising by depurination of the labile adducts that constitute 90% of all BP-DNA. adducts. Recent results suggest that 7-hydroxyBP (7-OHBP) specifically inhibits metabolism of BP 7,8-dihydrodiol to BP diol epoxide, but does not interfere with formation of BP radical cation. If so, 7-OHBP may provide a method to identify mechanisms of carcinogenic activation of PAH. To explore this, we propose (Aim #3) to determine the inhibitory effects of 7-OHBP on 1) formation of BP-and DMBA-DNA adducts by one-electron oxidation and monooxygenation, and 2) initiation of tumors by BP, DMBA and 5-methylchrysene in mouse skin. We expect 7-OHBP to inhibit tumor initiation by BP 7,8-dihydrodiol, DMBA 3,4-dihydrodiol and 5-methylchrysene, but not by BP and DMBA, that we think are mainly activated by one-electron oxidation. If so, this will open a new era of research in elucidating mechanisms of carcinogenesis of PAH.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
2R01CA025176-10A1
Application #
3166721
Study Section
Chemical Pathology Study Section (CPA)
Project Start
1979-07-01
Project End
1995-02-28
Budget Start
1992-03-01
Budget End
1993-02-28
Support Year
10
Fiscal Year
1992
Total Cost
Indirect Cost
Name
University of Nebraska Medical Center
Department
Type
Schools of Medicine
DUNS #
City
Omaha
State
NE
Country
United States
Zip Code
68198
Cavalieri, E; Frenkel, K; Liehr, J G et al. (2000) Estrogens as endogenous genotoxic agents--DNA adducts and mutations. J Natl Cancer Inst Monogr :75-93
Todorovic, R; Ariese, F; Devanesan, P et al. (1997) Determination of benzo[a]pyrene- and 7,12-dimethylbenz[a]anthracene-DNA adducts formed in rat mammary glands. Chem Res Toxicol 10:941-7
Casale, G P; Rogan, E G; Stack, D et al. (1996) Production of a high-affinity monoclonal antibody specific for 7-(benzo[alpha]pyren-6-yl) guanine and its application in a competitive enzyme-linked immunosorbent assay. Chem Res Toxicol 9:1037-43
Devanesan, P D; Higginbotham, S; Ariese, F et al. (1996) Depurinating and stable benzo[a]pyrene-DNA adducts formed in isolated rat liver nuclei. Chem Res Toxicol 9:1113-6
Cavalieri, E L; Rogan, E G (1995) Central role of radical cations in metabolic activation of polycyclic aromatic hydrocarbons. Xenobiotica 25:677-88
Rogan, E G; Devanesan, P D; RamaKrishna, N V et al. (1993) Identification and quantitation of benzo[a]pyrene-DNA adducts formed in mouse skin. Chem Res Toxicol 6:356-63
Todorovic, R; Devanesan, P D; Rogan, E G et al. (1993) 32P-postlabeling analysis of the DNA adducts of 6-fluorobenzo[a]pyrene and 6-methylbenzo[a]pyrene formed in vitro. Chem Res Toxicol 6:530-4
Devanesan, P D; RamaKrishna, N V; Padmavathi, N S et al. (1993) Identification and quantitation of 7,12-dimethylbenz[a]anthracene-DNA adducts formed in mouse skin. Chem Res Toxicol 6:364-71
Devanesan, P D; RamaKrishna, N V; Todorovic, R et al. (1992) Identification and quantitation of benzo[a]pyrene-DNA adducts formed by rat liver microsomes in vitro. Chem Res Toxicol 5:302-9
RamaKrishna, N V; Gao, F; Padmavathi, N S et al. (1992) Model adducts of benzo[a]pyrene and nucleosides formed from its radical cation and diol epoxide. Chem Res Toxicol 5:293-302

Showing the most recent 10 out of 24 publications